What amount sold does Intralink Spine, Inc. report in Form D filings?

The latest linked filings report $1.1M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Intralink Spine, Inc.'s most recent SEC filing?

Intralink Spine, Inc.'s most recent Form D filing was on 2016-11-29.

How many investors does Intralink Spine, Inc. have?

The most recent Form D filing lists 2 investor(s).

What type of securities does Intralink Spine, Inc. offer?

Intralink Spine, Inc.'s SEC Form D filings indicate equity offerings.

Intralink Spine, Inc.

CIK: 0001626172·Biotechnology·LEXINGTON, KY·Corporation

Reported Sold

$1,125,000

Total Filings

Identified Offerings

Last Filed

Nov 29, 2016

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Nov 29, 2016Form D — New notice

Reported sold: $800,000 · Target: $2,500,000

Rule 506(b)·2 investors

Dec 8, 2014Form D — New notice

Reported sold: $325,000 · Target: $1,800,000

Rule 506(b)·3 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$1,125,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Thomas Hedman

Related Person

Appears on 2 filings

LYLE HAWKINS

Related Person

Appears on 2 filings

JOHN THORNE

Related Person

Appears on 2 filings

MICHAL HAMMER

Related Person

Appears on 1 filing

MICHAEL HAMMER

Related Person

Appears on 1 filing

JOHN GOLLIHER

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 29, 2016	New	$2,500,000	$800,000	2
Dec 8, 2014	New	$1,800,000	$325,000	3

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Synomis, Inc.

Biotechnology

Offering target: $2,500,000

Filed Oct 29, 2026